1300 856 695
+44 203 514 0688
1800 867 1390If you would like to submit a blog post for consideration, please email admin@healthcert.com
[4 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [June 2019]
In this month’s skin cancer update video, Professor Giuseppe Argenziano continues his two-part discussion from last month about the role of Imiquimod in the treatment of lentigo maligna. Using real patient case examples, Giuseppe discusses Imiquimod in an adjuvant setting, including how it can be applied in a clinical setting after surgery has been performed.
Lentigo maligna is the most frequently recurring lesion locally. Giuseppe highlights the best-practice approach to treating lentigo maligna using a combination of both surgery and Imiquimod.
Watch the full skin cancer update now:
To learn more from Prof Giuseppe Argenziano:
1300 856 695
+44 203 514 0688
1800 867 1390
Thank you for the best-practice approach to treating lentigo maligna by using a combination of both surgery and Imiquimod.